NewcelX Ltd

Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
Returns
Key stats
Analyst consensus
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Financials
About NewcelX Ltd
NewcelX Ltd is a clinical-stage biopharmaceutical company focused on developing transformative therapies. Built on a validated human pluripotent stem cell (hPSC) platform, the Company's main program, NCEL-101, is designed to restore functional insulin production through scalable, off-the-shelf cell replacement. It is advancing a comprehensive therapeutic approach for Type 1 Diabetes, integrating cell therapy, immune protection, and translational science, including a phase IIa clinical trial for the treatment of Amyotrophic Lateral Sclerosis (ALS) in the field of regenerative medicine, as well as the development of treatments for Central Nervous System (CNS) disorders, including Narcolepsy, utilizing its Doxa platform. Its products are Holistic, IsletRx, AstroRx, and the DOXA platform.
Others were interested in
See all stocksFrequently asked questions
You need to open and fund a Saxo account to buy NewcelX Ltd stock. Once the account is approved, you can login to the platform (SaxoInvestor or SaxoTrader), search for NewcelX Ltd (by name) or ‘NCEL:xnas’ (by ticker), choose the number of shares you wish to buy, and place your order.
The ticker symbol for NewcelX Ltd is NCEL:xnas. You can use this code to find the stock in our platforms and track its price and performance.
NewcelX Ltd has its primary listing on NASDAQ (Small cap). You can trade NewcelX Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, NewcelX Ltd is available to trade on SaxoInvestor and SaxoTrader. You can buy NewcelX Ltd stock directly and include it as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like NewcelX Ltd or others.